RESUMO
Selenium is an essential element in human and animal metabolism integrated into the catalytic site of glutathione peroxidase (GPX1), an antioxidant enzyme that protects cells from damage caused by reactive oxygen species (ROS). Oxidative stress refers the imbalance between ROS and antioxidant defense systems. It generates alterations of DNA, proteins and lipid peroxidation. The imbalance occurs particularly during ischemia and lack of postmortem perfusion. This mechanism is of relevance in transplant organs, affecting their survival. The aim of this research is to evaluate the effect of seleno-methionine (SeMet) as a protective agent against postmortem ischemia injury in transplant organs. Wistar rats were orally administered with SeMet. After sacrifice, liver, heart and kidney samples were collected at different postmortem intervals (PMIs). SeMet administration produced a significant increase of Se concentration in the liver (65%, p < 0.001), heart (40%, p < 0.01) and kidneys (45%, p < 0.05). Levels of the oxidative stress marker malondialdehyde (MDA) decreased significantly compared to control in the heart (0.21 ± 0.04 vs. 0.12 ± 0.02 mmol g-1) and kidneys (0.41 ± 0.02 vs. 0.24 ± 0.03 mmol g-1) in a PMI of 1-12 h (p < 0.01). After SeMet administration for 21 days, a significant increase in GPX1 activity was observed in the liver (80%, p < 0.001), kidneys (74%, p < 0.01) and heart (35%, p < 0.05). SeMet administration to rats significantly decreased the oxidative stress in the heart, liver and kidneys of rats generated by postmortem ischemia.
Assuntos
Coração , Isquemia/metabolismo , Rim/metabolismo , Fígado/metabolismo , Selenometionina/metabolismo , Administração Oral , Animais , Feminino , Estresse Oxidativo , Ratos , Ratos Wistar , Selenometionina/administração & dosagem , Selenometionina/análiseRESUMO
The objective of this study was to determine whether supplementing the diets of laying hens with selenomethionine (SM, 1% selenium) improves performance and egg quality. We supplemented diets with SM as follows: T0 control (without SM); T5, T10, T15, and T20 were supplemented with 5, 10, 15, and 20 mg of SM/kg of feed, respectively (equal to 0.05, 0.10, 0.15, and 0.20 mg selenium/kg of feed). T5 and T10 hens showed better feed conversion per kg of egg, percentage of laying, higher daily feed intake, and higher average egg weight. The eggs of hens supplemented with SM had lower levels of lipoperoxidation (LPO) in fresh (T15 and T20) and stored eggs (T20). Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activities, as well as total antioxidant capacity were greater in egg yolks after storage (T10; T15; T20 compared to T0). Hens supplemented with SM had elevated GPx and SOD activities and decreased oxidative reactions. PRACTICAL APPLICATIONS: Selenium has several nutraceutical properties, with beneficial effects on the health of the animal and the food produced from them (eggs, in this case). Selenomethionine supplementation in the diet of laying hens improves productive efficiency, stimulates the antioxidant system and reduces lipid peroxidation in the egg yolk. Egg-laying hens that received selenomethionine showed minimized lipid peroxidation in stored eggs, possibly improving shelf life of the eggs.
Assuntos
Galinhas/metabolismo , Ovos/análise , Selenometionina/administração & dosagem , Ração Animal/análise , Animais , Antioxidantes , Suplementos Nutricionais/análise , Gema de Ovo/química , Feminino , Armazenamento de Alimentos , Glutationa Peroxidase/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Selênio/análise , Superóxido Dismutase/metabolismoRESUMO
The aim of the present study was to verify the effect of selenomethionine (SM) supplementation in the diet of chickens on performance, carcass yield, apparent retention, meat quality, and selenium (Se) deposition in tissues. In the first experiment, 2,100 day-old male chicks from the Hubbard Flex strain were randomly distributed in 84 plots with 12 treatments and 7 replicates. The treatments consisted of SM (1,600 ppm) supplementation at levels of 0.3 and 0.5 ppm in substitution of sodium selenite (45.7%) in different preslaughter phases. In the second experiment, 224 day-old male chicks from Hubbard Flex strain were randomly distributed in 28 metabolic cages. Poultry were distributed in 4 treatments with 7 replicates (8 poultry) in the experimental period from 1 to 21 D and experimental plot with 4 poultry aged from 22 to 42 D. Treatments consisted of 4 SM addition levels (0.3, 0.4, 0.5, and 0.6 ppm). In both experiments, the performance (1 to 21 and 1 to 42 D), carcass yield and cuts, apparent retention of Se (33 to 35 D), physical and chemical characteristics of the breast meat were evaluated: objective color, drip loss (DL), cooking loss (CL), pH, peroxide value, and Se deposition in tissues. In experiment I, it was found that SM at 0.3 ppm improved the weight gain and feed conversion of 1 to 42 D. The use of SM at 0.5 ppm resulted in lower DL and CL. The highest Se deposition in muscles was obtained using the SM at 0.5 ppm of 1 to 42 D. Using the SM at 0.5 ppm, only in the last week there was a deposition similar to the use of SM at 0.3 ppm of 1 to 42 D. In experiment II, it can be observed that increased SM levels provided lower DL and lower pH values. Se deposition in tissues of broiler chickens increased linearly at the SM level from 0.3 to 0.6 ppm.
Assuntos
Galinhas/fisiologia , Carne/análise , Selênio/metabolismo , Selenometionina/metabolismo , Fatores Etários , Ração Animal/análise , Animais , Dieta/veterinária , Suplementos Nutricionais/análise , Relação Dose-Resposta a Droga , Masculino , Distribuição Aleatória , Selenometionina/administração & dosagem , Distribuição TecidualRESUMO
Superoxide-hydrogen peroxide (S-HP) imbalance genetically caused by a gene polymorphism in the human manganese superoxide dismutase enzyme (Val16Ala-MnSOD) is associated with several diseases. Into mitochondria, MnSOD catalyses superoxide radical producing HP and oxygen. Ala-MnSOD genotype presents a high MnSOD efficiency and generates the highest HP concentrations that has been associated with the risk of several cancer types. Cellular selenoenzymes glutathione peroxidase and thioredoxin reductase (TrxR) and catalase (CAT) are essential to HP removal produced in excess in cells. Since, synthesis and activities of selenoenzymes are selenium dependent, we hypothesized that AA-MnSOD cells could have an improvement on antioxidant status undergoing Seleno-L-methionine (SeMet) treatment. This study performed an in vitro protocol to evaluate the response of peripheral blood mononuclear cells (PBMC) carriers of different Val16Ala-MnSOD genotypes exposed to SeMet. SeMet effects on cell viability, apoptosis induction and modulation of oxidative variables were determined using spectrophotometric, flow cytometry, fluorimetric and immunoassays. Gene modulation of antioxidant enzymes was also performed by qRT-PCR. From an initial protocol using heterozygous (AV) cells was determined that 1nM SeMet presented a cytoprotective effect. However, whereas this concentration did not change AA viability, in VV cells it was cytotoxic by increasing necrosis events. SeMet induced higher selenoenzymes levels in AA and VV cells and decreased oxidative markers levels including DNA damage. The results suggest a pharmacogenetic positive response of SeMet effect on AA-cells. Future studies in vivo could be essential to evaluate the potential clinical impact of S-HP imbalance after use of foods or supplements containing SeMet.
Assuntos
Peróxido de Hidrogênio/metabolismo , Leucócitos Mononucleares/efeitos dos fármacos , Polimorfismo Genético , Selenometionina/farmacologia , Superóxido Dismutase/genética , Superóxidos/metabolismo , Apoptose/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Relação Dose-Resposta a Droga , Humanos , Leucócitos Mononucleares/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Selenometionina/administração & dosagem , Relação Estrutura-Atividade , Superóxido Dismutase/metabolismoRESUMO
PURPOSE: To analyze the impact of selenium supplementation on serum antiTPO levels and thyroid echogenicity in patients with CAT, evaluating the response in subgroups with different GPx1 genotypes. METHODS: CAT patients (n = 55) with positive antiTPO were randomized to selenomethionine (SeMet) 200 µg daily (n = 28) or placebo (n = 27) for 3 months. Assessments included GPx1 genotyping at baseline and serum levels of plasma selenium, erythrocyte GPx1 activity, antiTPO and thyroid echogenicity at baseline, and 3 and 6 months. RESULTS: In the SeMet group, the increase in plasma levels of selenium and erythrocyte GPx1 activity was similar among patients with different GPx1 genotypes. In the overall cohort, patients randomized to SeMet showed a 5 % decrease in antiTPO levels at 3 months (p = non-significant) and 20 % at 6 months (p < 0.001 versus 3 months). In contrast, patients in the placebo group did not show significant changes in antiTPO levels at any time point. Subgroup analysis showed that patients with different GPx1 genotypes presented comparable responses in antiTPO levels and echogenicity index to SeMet. CONCLUSIONS: Selenium supplementation decreased serum antiTPO levels in CAT patients, with similar response among patients with different GPx1 genotypes.
Assuntos
Autoimunidade/efeitos dos fármacos , Suplementos Nutricionais , Glutationa Peroxidase/genética , Iodeto Peroxidase/imunologia , Selenometionina/uso terapêutico , Glândula Tireoide/efeitos dos fármacos , Tireoidite Autoimune/tratamento farmacológico , Adulto , Método Duplo-Cego , Feminino , Genótipo , Humanos , Inflamação/tratamento farmacológico , Inflamação/genética , Inflamação/imunologia , Masculino , Pessoa de Meia-Idade , Selenometionina/administração & dosagem , Glândula Tireoide/imunologia , Tireoidite Autoimune/genética , Tireoidite Autoimune/imunologia , Resultado do Tratamento , Adulto Jovem , Glutationa Peroxidase GPX1RESUMO
Avaliaram-se o efeito da suplementação de selênio, na dieta ofertada aos animais, sobre a concentração do mineral no sangue e no leite e as alterações nas características físico-químicas, contagem de células somáticas (CCS) e produção de leite. O experimento durou 63 dias, dos quais os primeiros 21 foram pré-experimental. Foram utilizadas 32 vacas em lactação da raça Jersey, as quais apresentavam, ao início, peso corporal de 402,5+58,4kg, escore de condição corporal de 3,19+0,31, produção de leite de 10,4+2,1kg e número de dias em lactação de 141,4+69,3. Os tratamentos foram: sem suplementação (grupo-controle); com suplementação de selênio inorgânico 0,3 (dieta-padrão + 0,3mg selenito de sódio/kg de concentrado - SI0,3); com suplementação com selênio orgânico 0,3 (dieta-padrão + 0,3mg seleniometionina/kg de concentrado - SO0,3) e com suplementação de selênio orgânico 0,6 (dieta-padrão + 0,6mg seleniometionina/kg de concentrado - SO0,6). As quantidades totais de selênio das dietas foram, respectivamente, 2,38; 4,18; 4,18 e 5,98mg/dia para os tratamentos controle, SI0,3, SO0,3 e SO0,6. O delineamento experimental foi o completamente ao acaso. O número de dias em lactação e os valores obtidos no início do experimento foram usados como covariáveis. Foram realizadas avaliações da produção de leite, do peso, da condição corporal, da composição do leite e do sangue nos dias 0, 14, 28 e 42 do período experimental. Entre os tratamentos, não foram detectadas alterações quanto à produção de leite, peso, condição corporal, características físico-químicas e microbiológicas do leite, e perfil bioquímico do sangue, exceto em relação à concentração de selênio no sangue entre o tratamento-controle e os tratamentos suplementados. Não houve diferenças quanto aos teores de selênio no sangue entre as fontes de selênio e as doses. Os teores de selênio no sangue evoluíram distintamente durante o experimento conforme a dose e a fonte. A suplementação com selênio ...(AU)
The effects of the dietary supplementation with selenium were evaluated on the concentration of the mineral in blood and milk, as well as changes in milk yield, physical and chemical characteristics, and somatic cells count (SCC). The trial lasted 63 days, the first 21 were designed to adaptation of animals to experimental conditions and standard diet. Thirty-two lactating Jersey cows were used and, at the beginning of the trial, they presented body weight of 402.5+58.4kg, body condition score of 3.19+0.31, milk yield of 10.4+2.1kg/day, and 141.4+69.3 days in milking. Treatments were: control (standard diet without added selenium), inorganic selenium (standard diet + 0.3mg sodium selenite/kg concentrate - SI0.3), organic selenium 0.3 (standard diet + 0.3mg selenomethionine/kg concentrate - SO0.3), and organic selenium 0.6 (standard diet + 0.6mg selenomethionine/kg concentrate - SO0.6). Total daily amounts of selenium were 2.38, 4.18, 4.18, and 5.98mg/cow, respectively, for control, SI0.3, SO0.3, and SO0.6 treatments. The trial was conducted as a completely randomized design. The number of days in milking and the values for all attributes measured at the end of the adaptation period were used as covariates. Measurements of body weight and condition score, milk yield and composition, and blood composition were performed on days 0, 14, 28, and 42 of the experimental period. No differences were detected among treatments for milk yield and composition, body weight and condition score, physical-chemical characteristics of milk, somatic cells count, and biochemical profile of the blood, except for Se contents of blood of control compared to supplemented. There were no differences caused by selenium sources or levels. Selenium supplementation did not alter neither milk nor blood components.(AU)
Assuntos
Animais , Proteínas de Ligação a Selênio/administração & dosagem , Proteínas de Ligação a Selênio/efeitos adversos , Proteínas de Ligação a Selênio/análise , Selenometionina/administração & dosagem , Selenometionina/efeitos adversos , Selenometionina/análise , Bovinos , Leite , Fenômenos Fisiológicos da Nutrição do LactenteRESUMO
Avaliaram-se o efeito da suplementação de selênio, na dieta ofertada aos animais, sobre a concentração do mineral no sangue e no leite e as alterações nas características físico-químicas, contagem de células somáticas (CCS) e produção de leite. O experimento durou 63 dias, dos quais os primeiros 21 foram pré-experimental. Foram utilizadas 32 vacas em lactação da raça Jersey, as quais apresentavam, ao início, peso corporal de 402,5+58,4kg, escore de condição corporal de 3,19+0,31, produção de leite de 10,4+2,1kg e número de dias em lactação de 141,4+69,3. Os tratamentos foram: sem suplementação (grupo-controle); com suplementação de selênio inorgânico 0,3 (dieta-padrão + 0,3mg selenito de sódio/kg de concentrado - SI0,3); com suplementação com selênio orgânico 0,3 (dieta-padrão + 0,3mg seleniometionina/kg de concentrado - SO0,3) e com suplementação de selênio orgânico 0,6 (dieta-padrão + 0,6mg seleniometionina/kg de concentrado - SO0,6). As quantidades totais de selênio das dietas foram, respectivamente, 2,38; 4,18; 4,18 e 5,98mg/dia para os tratamentos controle, SI0,3, SO0,3 e SO0,6. O delineamento experimental foi o completamente ao acaso. O número de dias em lactação e os valores obtidos no início do experimento foram usados como covariáveis. Foram realizadas avaliações da produção de leite, do peso, da condição corporal, da composição do leite e do sangue nos dias 0, 14, 28 e 42 do período experimental. Entre os tratamentos, não foram detectadas alterações quanto à produção de leite, peso, condição corporal, características físico-químicas e microbiológicas do leite, e perfil bioquímico do sangue, exceto em relação à concentração de selênio no sangue entre o tratamento-controle e os tratamentos suplementados. Não houve diferenças quanto aos teores de selênio no sangue entre as fontes de selênio e as doses. Os teores de selênio no sangue evoluíram distintamente durante o experimento conforme a dose e a fonte. A suplementação com selênio ...
The effects of the dietary supplementation with selenium were evaluated on the concentration of the mineral in blood and milk, as well as changes in milk yield, physical and chemical characteristics, and somatic cells count (SCC). The trial lasted 63 days, the first 21 were designed to adaptation of animals to experimental conditions and standard diet. Thirty-two lactating Jersey cows were used and, at the beginning of the trial, they presented body weight of 402.5+58.4kg, body condition score of 3.19+0.31, milk yield of 10.4+2.1kg/day, and 141.4+69.3 days in milking. Treatments were: control (standard diet without added selenium), inorganic selenium (standard diet + 0.3mg sodium selenite/kg concentrate - SI0.3), organic selenium 0.3 (standard diet + 0.3mg selenomethionine/kg concentrate - SO0.3), and organic selenium 0.6 (standard diet + 0.6mg selenomethionine/kg concentrate - SO0.6). Total daily amounts of selenium were 2.38, 4.18, 4.18, and 5.98mg/cow, respectively, for control, SI0.3, SO0.3, and SO0.6 treatments. The trial was conducted as a completely randomized design. The number of days in milking and the values for all attributes measured at the end of the adaptation period were used as covariates. Measurements of body weight and condition score, milk yield and composition, and blood composition were performed on days 0, 14, 28, and 42 of the experimental period. No differences were detected among treatments for milk yield and composition, body weight and condition score, physical-chemical characteristics of milk, somatic cells count, and biochemical profile of the blood, except for Se contents of blood of control compared to supplemented. There were no differences caused by selenium sources or levels. Selenium supplementation did not alter neither milk nor blood components.
Assuntos
Animais , Proteínas de Ligação a Selênio/administração & dosagem , Proteínas de Ligação a Selênio/análise , Proteínas de Ligação a Selênio/efeitos adversos , Selenometionina/administração & dosagem , Selenometionina/análise , Selenometionina/efeitos adversos , Bovinos , Leite , Fenômenos Fisiológicos da Nutrição do LactenteRESUMO
BACKGROUND: Brazil nuts provide a rich natural source of selenium, yet no studies have investigated the bioavailability of selenium in humans. OBJECTIVE: We investigated the efficacy of Brazil nuts in increasing selenium status in comparison with selenomethionine. DESIGN: A randomized controlled trial was conducted with 59 New Zealand adults. Participants consumed 2 Brazil nuts thought to provide approximately 100 mug Se, 100 mug Se as selenomethionine, or placebo daily for 12 wk. Actual intake from nuts averaged 53 mug Se/d (possible range: 20-84 mug Se). Plasma selenium and plasma and whole blood glutathione peroxidase (GPx) activities were measured at baseline and at 2, 4, 8, and 12 wk, and effects of treatments were compared. RESULTS: Plasma selenium increased by 64.2%, 61.0%, and 7.6%; plasma GPx by 8.3%, 3.4%, and -1.2%; and whole blood GPx by 13.2%, 5.3%, and 1.9% in the Brazil nut, selenomethionine, and placebo groups, respectively. Change over time at 12 wk in plasma selenium (P < 0.0001 for both groups) and plasma GPx activity in the Brazil nut (P < 0.001) and selenomethionine (P = 0.014) groups differed significantly from the placebo group but not from each other. The change in whole blood GPx activity was greater in the Brazil nut group than in the placebo (P = 0.002) and selenomethionine (P = 0.032) groups. CONCLUSION: Consumption of 2 Brazil nuts daily is as effective for increasing selenium status and enhancing GPx activity as 100 mug Se as selenomethionine. Inclusion of this high-selenium food in the diet could avoid the need for fortification or supplements to improve the selenium status of New Zealanders.
Assuntos
Bertholletia , Comportamento Alimentar , Glutationa Peroxidase/sangue , Selênio/sangue , Selenometionina/administração & dosagem , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nova Zelândia , Fatores de TempoRESUMO
Many studies evaluating the effects of selenium (Se) status on immunity utilize inorganic Se, although selenomethionine (Se-Met) has been suggested to be more bioavailable and less toxic. In the current study, we investigated the effects of dietary Se-Met on immune system function and cellular redox status in C57BL/6N female mice fed with low (0.02 ppm), sufficient (0.2 ppm, control group), or excess Se-Met (2 ppm) in the diet for 50 days. Low Se-Met intake reduced glutathione peroxidase (GPx) activity and glutathione concentration without modifying lipoperoxidation. While low Se-Met intake also reduced the number of B cells in the spleen, it increased mitogen-induced proliferation, IL-4 and IL-12 secretion when compared to the sufficient Se-Met intake group. In comparison to controls, excess Se-Met intake increased splenocyte proliferation and reduced B cell numbers, IL-4, and IL-12 secretion without affecting oxidative stress markers. These data suggest that Se-Met supplementation should be carefully evaluated as it many influence immune function.